Are CBD Stores Still Profitable? 2026 Revenue Data

In its U.S. Hemp Cannabinoid Report for 2026, Whitney Economics found that 69.9% of hemp retailers said they’d go out of business if the federal restrictions on intoxicating hemp THC take effect as written on December 11. Meanwhile, average revenue per hemp store climbed to $859,000 in 2026, up from $815,000 in 2023, based on 496 hemp operators across 35 states (no national licensing regime tracks hemp retailers, so even the store count is a range: an estimated 35,198 to 67,474 outlets nationally).

This seeming paradox is really just the reality of working in a business facing policy risk. The good news is that, for now, it's a regulatory deadline retailers can still plan around and not a done deal. Below, we’ll dig into what CBD and smoke shop retailers actually keep after costs, how lenders price the category (it's not what most operators assume), what's been pulling revenue around even before this rule change, and three ways the next 12 months could go.

Key Takeaways

• Average revenue per hemp retail store reached $859,000 in 2026, up from $815,000 in 2023, even as 69.9% of retailers say they'd close under the December restrictions as written.
• No published source reports a profitability rate or gross margin for CBD and hemp retail specifically. The closest figure, 82.9% of hemp businesses reporting profitability, covers the entire supply chain, cultivation and manufacturing included.
• Smoke shops sold through business brokers in 2025 posted median owner earnings of 21.5% of revenue, and 23.8% across the five years to 2025.
• Smoke shops repay federal small business loans at close to the retail average, charging off at 9.4% against 9.0% for retail overall.
• Our read on the most likely outcome: a smaller, more professional market, where operators who exit early lose the most and diversified retailers pick up their share.

What Does a CBD or Smoke Shop Store Actually Earn?

The clearest available figures put average hemp retail revenue at $859,000 per store in 2026, up from $815,000 in 2023, according to Whitney Economics. That's the number that answers "is this business growing?" A second, independent dataset adds detail the survey doesn't capture: what these stores actually sell for, and what their owners actually take home.

The BizBuySell figures come from businesses that were actually listed and sold, which skews toward operations healthy enough to attract a buyer.

What Is a Typical Smoke Shop Profit Margin?

Smoke shops sold through business brokers in 2025 reported owner earnings equal to 21.5% of revenue, and 23.8% across the five years to 2025, according to BizBuySell. That figure is Seller's Discretionary Earnings, not gross margin, and the two are not comparable answers to the same question.

Seller's Discretionary Earnings is profit after operating costs, with the owner's salary, personal expenses, interest, tax, and depreciation added back. Gross margin sits at the opposite end of the income statement: revenue minus cost of goods sold, before any operating expense is subtracted. A retailer asking "what's a good CBD profit margin?" is usually mixing the two, which is why figures found elsewhere online rarely reconcile with each other.

No agency or research body publishes a gross margin figure for CBD retail specifically. A tobacco and e-cigarette retail benchmark does exist, compiled by RMA from the financial statements banks hold on their own borrowers, available as a paid report starting at $210. That's a fact about what data exists, not a substitute for a CBD-specific number.

The falling sale price tells its own story: a median multiple of 1.98x earnings and 0.47x revenue puts smoke shops near the bottom of retail comparables, evidence that buyer confidence was softening before any federal restriction entered the picture.

It's also worth separating what a CBD brand earns from what a CBD store earns; they aren't the same question. Publicly traded hemp brands report gross margins well above what a retailer sees: cbdMD posted a 62.4% gross margin in FY2025, CV Sciences 49.0%, and Charlotte's Web 43.5%, all from SEC filings. Those are manufacturer and brand economics, not retail economics, and shouldn't be quoted as what a store owner can expect to keep.

For a side-by-side on cannabis retail specifically, see how much money a cannabis dispensary owner makes.

Is Selling CBD Profitable in 2026?

There's no single yes or no answer. No published source reports a profitability rate for CBD or hemp retail specifically, but the indicators available point up: average revenue per hemp store rose to $859,000 in 2026, up from $815,000 in 2023, and smoke shops sold through business brokers in 2025 kept 21.5% of revenue as owner earnings.

How Do Lenders See CBD and Smoke Shop Retail?

Smoke shops repay federal small business loans at close to the rate of retail generally, charging off at 9.4% against a 9.0% retail average, based on SBA 7(a) loan-level records for loans approved between 2010 and 2019 (a window long enough for most of those loans to have resolved, measuring charge-offs against loans paid in full).

That result runs counter to how a lot of people in this space assume the category is viewed. Standalone CBD shops sit closer to the health supplement and personal care lines above, where the risk premium lenders price in runs roughly 50% above the retail average. Capital access has been thin regardless. Across the same SBA records, only 16 businesses with "CBD" in their name have ever received a 7(a) loan, totaling $8.4 million, against 226 for "vape" and 79 for "smoke shop." Those three counts are matched on business names across all industry codes, so a portion of them may not be retailers at all. SBA policy effective June 1, 2025 made consumable hemp products ineligible for 7(a) and 504 lending outright, which explains part of the gap.

Here’s the counterpoint: lending to these broader categories is at decade highs. Tobacco and e-cigarette approvals rose from 42 in FY2021 to 70 in FY2025, health supplement retail hit 106, and other health and personal care retail hit 129. Those industry codes cover a lot of businesses that sell no hemp products at all, which accounts for the gap. Lenders are still funding the broader categories; it's the CBD-specific and consumable hemp products that are now excluded.

The practical takeaway for an operator? Plan for self-funding or alternative capital sources rather than counting on an SBA-backed loan for CBD-specific inventory or buildout, and price that into your working capital planning the same way you'd price out a processor switch.

What Was Squeezing CBD Retailers Before the Rules Changed?

Two forces were already squeezing CBD and hemp retailers before a major policy change entered the conversation: competition from adjacent product categories, and a cost structure specific to the category.

Channel competition is the bigger of the two. Convenience stores now sell more THC beverages than any retail channel except liquor stores, and Circle K began rolling hemp-derived THC seltzers into roughly 3,000 stores in April 2026, moving inventory that used to be a specialty retailer's advantage onto a shelf next to gas pumps. There is a precedent for this: in convenience retail, cigarettes fell from 30.9% of in-store sales in 2015 to 18.8% in 2024, while other tobacco products rose from 4.2% to 7.6% over the same period, according to NACS. A decade of one category declining while an adjacent one grows is a familiar retail pattern, and it's why retailers who track performance at the category level, rather than the store level, catch the shift while it's happening instead of after.

Cost pressure compounds the category shift. Convenience store operating expenses rose 23.3% since 2021 and have outpaced pretax profit for five straight years, per NACS. A CBD-specific retailer carries cost lines a general retailer doesn't: high-risk payment processing, elevated insurance, mainstream processors continuing to withdraw from the category, and the added cost of handling cash when card acceptance gets harder. Both of those last two are worth a closer look and a review of what cash actually costs a retailer to carry.

Where Is the Money Going Instead?

THC beverage sales reached $239 million over a trailing 52 weeks, up 135% year over year, according to NielsenIQ retail scan data. SPINS, using a different methodology, shows delta-9 beverages up 148% over a comparable period. A separate figure from the Hemp Beverage Alliance shows case equivalents rising from 692,435 to 1,616,075, up 133%, but that number measures wholesale depletions from 26 brands, not retail sell-through.

Nicotine pouches are the other adjacent growth category, projected at a 29.6% compound annual growth rate through 2030.

It's worth being precise about what the December restrictions actually target: intoxicating hemp THC. CBD isolate, verified zero-THC broad-spectrum products, topicals, and hemp food are unaffected. The stores facing the most exposure are the ones that rebuilt their revenue on delta-8 and THCA flower after 2018 while keeping the "CBD" sign over the door.

Beverage growth carries its own caveat: it's most exposed to the December rules outside states with more permissive frameworks, so any retailer building a plan around it should treat it as conditional on geography, or on reformulation toward compliant, non-intoxicating formats.

For broader market context: U.S. CBD retail sales fell from $3.8 billion in 2023 to $3.4 billion in 2024, per Brightfield Group.

What Happens Next? Three Scenarios for Hemp Retail

No single outcome is certain yet, so here we’re laying out three – in order from most to least likely – along with what each one means for an operator deciding whether to invest, hold, or exit.

Most likely: a smaller market with stronger operators. Federal restrictions reshape the intoxicating hemp market, but enforcement and regulation continue to vary by state. Profitability gets harder, particularly for retailers leaning heavily on high-potency hemp products. Operators with good locations, disciplined costs, a diversified product mix, and access to compliant hemp categories stay viable. Weaker operators exit, and stronger retailers pick up a larger share of a smaller, more professional market. This is the scenario we consider most likely, largely because enforcement has already varied significantly by state at every stage of this process, and the federal effective date has already moved twice.

Less likely: hemp retail economics break down. The December rules take effect largely as written and are meaningfully enforced. The intoxicating hemp products that have been driving specialty retail sales become unavailable or commercially impractical, and retailers dependent on that revenue can't replace it with compliant CBD and non-intoxicating products alone. Stores in this scenario close, consolidate, or pivot into smoke, vape, supplements, and general retail.

Best case: regulated hemp becomes a sustainable category. Congress delays or revises the framework and builds a workable, age-gated pathway for hemp-derived products, with clear standards for testing, labeling, potency, and retail access. Regulatory certainty lets retailers plan inventory and invest with confidence. Operators who combine compliant hemp-derived products with CBD, wellness, and adjacent categories build durable businesses, and specialty hemp retail matures into a genuinely regulated segment.

One thread runs through all three: concentration risk. Your store's exposure to the December restrictions depends almost entirely on what share of its revenue sits in the products at risk, and that share is measurable today, well before any of these scenarios plays out.

What Protects Profit in Any of Them?

A store earning 80% of its revenue from a single category isn't more profitable than a diversified one; it's more exposed. That's the mechanism behind every scenario above, and it's the one thing you can act on regardless of which one arrives.

Texas offers the clearest recent example of how fast a shelf can turn over. Retailers there watched vapes, then flower, then alt-cannabinoids come off the shelf within a single year, while per-location registration fees rose from $155 to $5,150. The lesson isn't the size of any individual retailer's losses; it's how quickly a category's availability can shift once a state moves.

Operators navigating that kind of shift describe a consistent set of habits: knowing margin and turn rate by category rather than by day, cutting SKUs that stop moving before they become dead inventory, and going deep on a smaller number of proven sellers rather than wide across a long tail of untested products.

That level of visibility is a reporting and inventory problem before it's anything else. A POS system that reports margin and velocity at the category level, and lets an operator adjust a catalog across every location quickly, is what turns "we should diversify" into a decision you can actually make this week.

FAQ

How do CBD store economics differ from a dispensary?

There's no published profitability figure for CBD retail specifically, so a direct "which is more profitable" comparison isn't answerable from available data. What can be answered is the structural difference: dispensaries carry 280E federal tax exposure and licensing costs that CBD retailers don't face, while CBD retailers deal with banking and lending exclusion that dispensaries only partly share. For dispensary-specific income figures, see how much a cannabis dispensary owner makes.

Is the CBD market saturated?

The clearest evidence points to consolidation upstream rather than saturation at the store level. CBD companies of all kinds, brands and manufacturers included, fell from roughly 3,500 at the post-2018 peak to under 1,500, per Brightfield Group. Meanwhile, hemp retail outlets are estimated between 35,198 and 67,474, per Whitney Economics. Fewer suppliers and more places to buy from them describes consolidation among brands, not a shortage of retail competition, and it's worth understanding which pressure you're actually facing before reacting to either number.

How do you work out your own profit margin?

Start by separating two different numbers that get treated as the same thing: Seller's Discretionary Earnings (profit after operating costs, with the owner's salary and other add-backs restored) and gross margin (revenue minus cost of goods sold, before any operating expense). They answer different questions, so a figure for one isn't a substitute for the other. Beyond that distinction: a category can carry a healthy gross margin and still contribute almost nothing to your bottom line in absolute dollars if it's a small share of sales. Category-level reporting, not a single store-wide margin figure, is what actually tells you where your profit is coming from.

Do vape shops and smoke shops have different margins?

No dataset breaks the two apart cleanly. BizBuySell groups vape shops inside its smoke shop category for valuation purposes. The one split that is measurable comes from SBA lending data, where businesses with "vape" in the name charge off at 10.3% against 9.5% for businesses named "smoke shop," a small gap that doesn't support a strong conclusion either way.

The Bottom Line

The likeliest outcome for hemp retail is a smaller, more professional market, and what determines who's still standing in it isn't the market itself; it's how concentrated a store's revenue is in the categories most exposed on December 11, 2026.

Three things hold regardless of which scenario arrives: work out what share of your revenue sits in the categories facing the most exposure this December, review margin and turn rate by category rather than by day, and talk to your payment processor before the rules change rather than after.

See how Cova's cannabis POS gives operators category-level visibility into margin and velocity, so the diversification decision is a data-backed one rather than a guess.